Not eating healthy while taking GLP-1s can pose several risks, including: Hypoglycemia: GLP-1s help lower blood sugar levels, but eating unbalanced meals or skipping meals can lead to hypoglycemia (low blood sugar)
Generally, it is advised that donors should have stable blood pressure without any negative effects for at least three months before donating blood
Providing guidance on cleaning techniques and regular maintenance helps prevent errors caused by damaged or improperly maintained meters, ensuring reliable SMBG results
For patients with BMI 35 kg/m (regardless of comorbidities) or BMI 30-34.9 kg/m with metabolic disease, bariatric surgery consultation may be appropriate, according to 2022 American Society for Metabolic and Bariatric Surgery guidelines
Wegovycontains semaglutide and should not be used with other semaglutide-containing products or other GLP-1 receptor agonist medicines
Final Thoughts Semaglutide and tirzepatide can both create significant digestive side effects because they intentionally slow digestion and alter appetite signaling